{"id":"W2766948867","doi":"10.1182/blood-2017-06-791228","title":"Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ixazomib; Multiple myeloma; Progression-free survival; Refractory (planetary science); Medicine; Lenalidomide; Oncology; Internal medicine; Pomalidomide; Overall survival; Carfilzomib; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874105,0.000269964,0.0004561605,0.0001689258,0.0003655908,0.00008907424,0.0005166465,0.0001889096,0.00009643305],"category_scores_gemma":[0.002263399,0.0002041027,0.0001090029,0.00009457204,0.0001816811,0.0002309365,0.0003009141,0.0004933476,0.000165777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007762636,"about_ca_system_score_gemma":0.0001797365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007529997,"about_ca_topic_score_gemma":0.0003522287,"domain_scores_codex":[0.9973944,0.0001832397,0.0003619747,0.0005425328,0.0008686229,0.000649223],"domain_scores_gemma":[0.9974393,0.000132549,0.0002947222,0.001571615,0.0001638085,0.0003979872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007631091,0.00462917,0.9443148,0.00006623256,0.0001844223,0.0006853529,0.0001189614,1.16787e-7,0.0003841815,0.00002536885,0.0002416419,0.04858659],"study_design_scores_gemma":[0.03460676,0.001552642,0.9596325,0.0001911653,0.0001266137,0.00000625443,0.00002594196,0.00001674842,0.003088395,0.0002035873,0.00036414,0.0001852488],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948037,0.0001422574,0.000002715833,0.000324941,0.0002331864,0.001388041,0.0001069496,0.00007394277,0.002924323],"genre_scores_gemma":[0.9977993,0.0001106411,0.0009244447,0.0000214761,0.0001814764,0.0002004745,0.0001122586,0.00004938245,0.0006005532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04840134,"threshold_uncertainty_score":0.8323066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01918654123332542,"score_gpt":0.2931582333603844,"score_spread":0.273971692127059,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}